Viewing Study NCT05762393


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-02-21 @ 11:19 PM
Study NCT ID: NCT05762393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-02
First Post: 2023-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar
Sponsor: International Vaccine Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schistosomiasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccine View
None Schistosomiasis View